Literature DB >> 21054593

Abolition of prescription charges in Wales: the impact on medicines use in those who used to pay.

Sam Groves1, David Cohen, M Fasihul Alam, Frank D J Dunstan, Philip A Routledge, Dyfrig A Hughes, Susan Myles.   

Abstract

OBJECTIVES: patient co-payments for prescription medicines in Wales were abolished in April 2007 and there has been much speculation on the possible effects. We analysed patient-reported use of medicines before and after abolition of the prescription charge, noting changes in the number of items prescribed, number of non-prescription medicines purchased and participants not collecting all prescribed items (primary non-adherence).
METHODS: a sample of community pharmacists across Wales (n = 249) issued questionnaires to customers at the point of dispensing who were not exempt from the prescription charge. A second questionnaire was delivered by post to those who returned the first questionnaire (n = 1027) and expressed a willingness to participate further. Paired t-tests were applied to responses from those completing both questionnaires (n = 593). Further analyses were carried out according to gender, age and reported levels of household income. KEY
FINDINGS: there was a statistically significant (P = 0.03) rise in the number of items prescribed, and a statistically significant fall (P = 0.02) in the number of non-prescription medicines purchased. Primary non-adherence was also found to fall between pre- and post-abolition periods. Those most affected in terms of increase in number of prescribed items prescribed were the older age group (45-59 years), and those with household income of between £15600 and £36400. The most affected in the fall in number of medicines purchased were males, those in the lower age group (25-34 years) and those with a higher household income (>£36400).
CONCLUSIONS: although the rise in number of items prescribed and fall in number of medicines purchased was generally anticipated, there appeared to be little or no effect for those on the lowest incomes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054593     DOI: 10.1111/j.2042-7174.2010.00063.x

Source DB:  PubMed          Journal:  Int J Pharm Pract        ISSN: 0961-7671


  4 in total

1.  Impact of abolishing prescription fees in Scotland on hospital admissions and prescribed medicines: an interrupted time series evaluation.

Authors:  Andrew James Williams; William Henley; John Frank
Journal:  BMJ Open       Date:  2018-12-18       Impact factor: 2.692

2.  Changes in prescribing rates of sodium-containing medications in the UK from 2009 to 2018: a cross-sectional study with interrupted time series analysis.

Authors:  Chengsheng Ju; Li Wei; Isla S Mackenzie; Thomas M MacDonald; Jacob George
Journal:  BMJ Open       Date:  2021-02-17       Impact factor: 2.692

3.  Medicines prescribed by non-medical independent prescribers in primary care in Wales: a 10-year longitudinal study April 2011-March 2021.

Authors:  Paul Deslandes; Hannah Blowers; Kath Haines; Karen Hodson; Rhian Deslandes
Journal:  BMJ Open       Date:  2022-02-24       Impact factor: 2.692

4.  Is 50 cent the price of the optimal copayment? - a qualitative study of patient opinions and attitudes in response to a 50 cent charge on prescription drugs in a publicly funded health system in Ireland.

Authors:  Sarah-Jo Sinnott; Marie Guinane; Helen Whelton; Stephen Byrne
Journal:  BMC Health Serv Res       Date:  2013-01-10       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.